Autoimmune Hemolytic Anemia Treatment in Turkey – Best Hospitals & Doctors

Learn about Autoimmune Hemolytic Anemia Treatment in Turkey — how it works, who it is for, recovery timelines, and what to expect before and after surgery. Compare hospitals and doctors experienced in Autoimmune Hemolytic Anemia and request assistance for cost estimates or appointments.

Partner Hospitals

3 partner in Turkey for this surgery

Specialist Doctors

0 Surgeons linked to this surgery

Treatment Cost

USD 120,788 – USD 281,838

About Autoimmune Hemolytic Anemia

Bone Marrow Transplantation (BMT) for Autoimmune Hemolytic Anemia (AIHA) is a definitive, potentially curative procedure for severe, refractory cases. This treatment involves replacing a patient's dysfunctional immune system, which is mistakenly destroying its own red blood cells, with a healthy one from a donor (allogeneic transplant) or from the patient's own treated cells (autologous transplant). The goal is to 'reset' the immune system, halting the autoimmune attack. It is considered a high-risk, high-reward intervention reserved for patients who have not responded to standard therapies like corticosteroids, immunosuppressants, or rituximab. The procedure requires meticulous patient selection, thorough preparation, and long-term follow-up to manage risks like graft-versus-host disease and infections.

Key Highlights

Offers a potential cure for severe, treatment-resistant Autoimmune Hemolytic Anemia.Aims to completely reset the malfunctioning immune system responsible for red blood cell destruction.Can eliminate or drastically reduce the need for long-term immunosuppressive medications.May improve long-term survival and quality of life in carefully selected patients.Utilizes advanced medical technology and a multidisciplinary team approach.

Who is this surgery for?

Severe, life-threatening AIHA that does not respond to first-line treatments (corticosteroids, IVIG).
AIHA that is refractory to second-line therapies like rituximab or other immunosuppressants.
Patients who experience severe side effects from long-term immunosuppressive therapy.
AIHA associated with an underlying hematologic malignancy (like lymphoma) where transplant addresses both conditions.
Selected cases of recurrent or chronic AIHA causing significant morbidity and impacting quality of life.

How to prepare

Comprehensive evaluation including blood tests, imaging (CT/PET scans), and heart/lung function tests.
Identification and compatibility testing (HLA typing) of a suitable donor (sibling, unrelated donor, or cord blood).
Dental check-up and clearance to prevent infection sources.
Fertility preservation counseling and procedures, if desired.
Administration of conditioning therapy (chemotherapy +/- radiation) to destroy the existing bone marrow and suppress the immune system.
Central venous catheter placement for medication administration and blood draws.
Psychological counseling and detailed informed consent process.

Risks & possible complications

Graft-versus-host disease (GVHD), where donor immune cells attack the patient's body.
Graft failure, where the new bone marrow does not engraft or function.
Severe infections due to prolonged immune suppression before engraftment.
Organ toxicity (e.g., liver, lungs, heart) from conditioning chemotherapy/radiation.
Bleeding and anemia until the new marrow produces blood cells.
Long-term risks include secondary cancers, cataracts, and infertility.

Recovery & hospital stay

Initial hospital stay of 4-6 weeks in a sterile environment to prevent infection until engraftment occurs.
Close monitoring of blood counts, signs of infection, and GVHD.
Multiple blood and platelet transfusions may be required initially.
Immunosuppressive medications (like cyclosporine) to prevent GVHD, tapered slowly over months.
After discharge, frequent outpatient visits for monitoring and management of complications.
Recovery of immune function is gradual; patients must avoid crowds and practice strict hygiene for several months to a year.
Long-term follow-up is essential to monitor for late effects and disease recurrence.

Typical hospital stay: 4-6 weeks
Expected recovery time: 6-12 months for full immune recovery and return to normal activities

Frequently Asked Questions

If you are considering autoimmune hemolytic anemia in Turkey, these questions and answers can help you make a confident, informed decision.

＋ − Which hospitals are best for autoimmune hemolytic anemia in Turkey?

Popular choices for autoimmune hemolytic anemia in Turkey include Liv Hospital Bahçeşehir, Istinye Üniversitesi Hastanesi Liv, Liv Hospital Ankara, known for experienced specialists and advanced surgical infrastructure.

＋ − How do I choose the right doctor for autoimmune hemolytic anemia?

Look at the doctor’s years of experience, hospital association, patient reviews, and how often they perform autoimmune hemolytic anemia. MediFyr helps you compare bone marrow transplant specialists and book consultations online.

＋ − What factors affect the cost of autoimmune hemolytic anemia?

The overall cost depends on hospital category, surgeon’s experience, room type, implant or device used (if any), length of stay, tests, and post-operative care. Our team can help you get cost estimates from multiple hospitals before you decide.

Get assistance for Autoimmune Hemolytic Anemia

Share a few details and our team will help you compare hospitals, understand costs, and schedule a consultation with the right specialist.

Real People Helping Real Patients!
Get Assistance.

Procedure cost in other countries

Here is an overview of how the estimated cost, hospital stay, and recovery time for autoimmune hemolytic anemia compare across other countries where we have data.

Country	Estimated cost range	Typical stay	Recovery time	View details
India	USD 16,315 – USD 38,069	4-6 weeks	~ 6-12 months for full immune recovery and return to normal activities	Know More
Turkey	USD 120,788 – USD 281,838	4-6 weeks	~ 6-12 months for full immune recovery and return to normal activities	Know More

Top hospitals for Autoimmune Hemolytic Anemia in Turkey

These partner hospitals in Turkey have dedicated bone marrow transplantation teams and experience managing patients undergoing autoimmune hemolytic anemia.